Delivery Order SPE2DB22D2211-SPE2DB25FSEME
- Not listed
- The Defense Logistics Agency awarded a $2,093.98 delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 15, 2025. This firm fixed-price contract was competitively awarded without set-aside designations and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for the supply of Valtoco 10 mg nasal sprays. This firm fixed price delivery order, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, was awarded without a set-aside designation through competitive procurement. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,309.22 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with a completion date of July 28, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded on July 26, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania headquarters. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $5,644.86 to AmerisourceBergen Drug Corp for the supply of Valtoco 15 mg nasal sprays. This firm fixed-price contract, awarded on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,216.96 to supply Valtoco 10 mg nasal sprays, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be performed at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with a completion date of September 3, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,128.26 to AmerisourceBergen Drug Corp for Valtoco 20 mg nasal sprays, with a completion date of July 31, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The product being delivered is Valtoco, an FDA-approved nasal spray medication used for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, valued at $4,518.48 under a firm fixed price contract. The award, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a non-competitive delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's headquarters location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays under a firm fixed-price contract with a ceiling value of $1,543.14. The award was made on August 4, 2025, with an ultimate completion date of August 5, 2025. This is a non-set-aside, competitively awarded delivery order that will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal spray, a medication used for acute seizure treatment. This competitive, firm fixed-price delivery order, valued at $4,685.26, was executed on August 12, 2025, with an ultimate completion date of August 13, 2025. The contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger federal contract portfolio. Performance will occur at the company's...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSEMEDelivery Order
The Defense Logistics Agency awarded a $2,259.24 delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of September 9, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA. The product will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's existing $999,999,999 indefinite delivery contract with DLA Troop Support Medical (SPE2DX), which provides comprehensive pharmaceutical support through December 2026. Valtoco is a nasal spray formulation used for acute seizure management and represents the type of specialized pharmaceutical product within the contractor's established medical supply portfolio. AmerisourceBergen's role as a prime pharmaceutical distributor to the Defense Logistics Agency's Medical Supply Chain enables it to fulfill critical medication needs across military and veteran healthcare systems on a competitive basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 9/8/25 |